Cantargia Publishes Data Validating IL1RAP as a Key PDAC Target
LUND, Sweden, June 27, 2026 Cantargia AB announced the publication of new preclinical and clinical findings in JCI Insight,...
KRAS
Advertisement
Oncolytics’ Pelareorep Shows Strong KRAS-Targeted Immune Activation at ASCO 2026
SAN DIEGO, May 22, 2026 Oncolytics Biotech® announced new translational data from its GOBLET and AWARE-1 studies showing that...
Advertisement
